PortfoliosLab logoPortfoliosLab logo
EWTX vs. SPRY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EWTX vs. SPRY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edgewise Therapeutics Inc (EWTX) and Silverback Therapeutics Inc (SPRY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EWTX achieves a 60.10% return, which is significantly higher than SPRY's -34.68% return.


EWTX

1D
-3.73%
1M
14.07%
6M
59.24%
YTD
60.10%
1Y
185.21%
3Y*
76.55%
5Y*
12.98%
10Y*

SPRY

1D
-1.68%
1M
-22.03%
6M
-32.71%
YTD
-34.68%
1Y
-57.49%
3Y*
3.67%
5Y*
-24.00%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

EWTX vs. SPRY - Yearly Performance Comparison


2026 (YTD)20252024202320222021
EWTX
Edgewise Therapeutics Inc
60.10%-7.06%144.06%22.37%-41.49%-43.41%
SPRY
Silverback Therapeutics Inc
-34.68%10.43%92.52%-35.76%28.08%-86.68%

Correlation

The correlation between EWTX and SPRY is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.26

Fundamentals

Market Cap

EWTX:

$4.27B

SPRY:

$755.70M

EPS

EWTX:

-$1.67

SPRY:

-$2.00

PB Ratio

EWTX:

8.63

SPRY:

12.33

Total Revenue (TTM)

EWTX:

$0.00

SPRY:

$98.99M

Gross Profit (TTM)

EWTX:

$0.00

SPRY:

$59.93M

EBITDA (TTM)

EWTX:

-$188.16M

SPRY:

-$194.60M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EWTX vs. SPRY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EWTX
EWTX Risk / Return Rank: 9595
Overall Rank
EWTX Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
EWTX Sortino Ratio Rank: 9494
Sortino Ratio Rank
EWTX Omega Ratio Rank: 9191
Omega Ratio Rank
EWTX Calmar Ratio Rank: 9898
Calmar Ratio Rank
EWTX Martin Ratio Rank: 9898
Martin Ratio Rank

SPRY
SPRY Risk / Return Rank: 1111
Overall Rank
SPRY Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
SPRY Sortino Ratio Rank: 1111
Sortino Ratio Rank
SPRY Omega Ratio Rank: 1212
Omega Ratio Rank
SPRY Calmar Ratio Rank: 77
Calmar Ratio Rank
SPRY Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EWTX vs. SPRY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edgewise Therapeutics Inc (EWTX) and Silverback Therapeutics Inc (SPRY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWTXSPRYDifference
Sharpe ratioReturn per unit of total volatility

+3.28

Sortino ratioReturn per unit of downside risk

+4.50

Omega ratioGain probability vs. loss probability

1.39

0.86

+0.53

Calmar ratioReturn relative to maximum drawdown

9.52

-0.91

+10.43

Martin ratioReturn relative to average drawdown

24.82

-1.24

+26.06

EWTX vs. SPRY - Sharpe Ratio Comparison

The current EWTX Sharpe Ratio is 2.46, which is higher than the SPRY Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of EWTX and SPRY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EWTX vs. SPRY - Drawdown Comparison

The maximum EWTX drawdown since its inception was -84.69%, smaller than the maximum SPRY drawdown of -95.20%. Use the drawdown chart below to compare losses from any high point for EWTX and SPRY.


Loading charts...

Drawdown Indicators


EWTXSPRYDifference

Max Drawdown

Largest peak-to-trough decline

-84.69%

-95.20%

+10.51%

Max Drawdown (1Y)

Largest decline over 1 year

-19.59%

-63.32%

+43.73%

Max Drawdown (3Y)

Largest decline over 3 years

-68.81%

-63.32%

-5.49%

Max Drawdown (5Y)

Largest decline over 5 years

-75.41%

-91.77%

+16.36%

Current Drawdown

Current decline from peak

-17.83%

-87.40%

+69.57%

Average Drawdown

Average peak-to-trough decline

-52.76%

-78.34%

+25.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.51%

46.35%

-38.84%

Volatility

EWTX vs. SPRY - Volatility Comparison

The current volatility for Edgewise Therapeutics Inc (EWTX) is 21.68%, while Silverback Therapeutics Inc (SPRY) has a volatility of 31.30%. This indicates that EWTX experiences smaller price fluctuations and is considered to be less risky than SPRY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWTXSPRYDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.68%

31.30%

-9.62%

Volatility (6M)

Calculated over the trailing 6-month period

45.27%

49.92%

-4.65%

Volatility (1Y)

Calculated over the trailing 1-year period

75.84%

70.33%

+5.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.63%

80.62%

+1.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.11%

81.23%

-0.12%

Dividends

EWTX vs. SPRY - Dividend Comparison

Neither EWTX nor SPRY has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

EWTX vs. SPRY - Financials Comparison

This section allows you to compare key financial metrics between Edgewise Therapeutics Inc and Silverback Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
22.68M
(EWTX) Total Revenue
(SPRY) Total Revenue
Values in USD except per share items

Frequently Asked Questions


EWTX and SPRY have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPRY has higher volatility (31.30%) compared to EWTX (21.68%). In terms of maximum drawdown, EWTX dropped -84.69% vs SPRY's -95.20%.

EWTX currently has the higher Sharpe Ratio (2.46 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EWTX and SPRY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer